In vivo binding of the radioiodinated peptide YIGSR on B16 melanoma cells

Invasion and Metastasis

Volumn 16, Issue 6, 1996, Pages 322-329

  Kouzi Koliakos, Kokkona ^a   Koliakos, George ^a,c   Trontzos, Christos ^a   Papageorgiou, Athanasios ^b   Iliadis, Stavros ^a   Triantos, Athanasios ^a   Dimitriadou, Aphrodite ^a   Kanellaki, Mary ^a  

^a AHEPA UNIVERSITY HOSPITAL   (Greece)

^b Theagenion Medical Institute   (Greece)

^c NONE   (Greece)

Author keywords

Laminin receptors; Melanoma; YIGSR

Indexed keywords

IODINE 125; LAMININ; LAMININ RECEPTOR; PENTAPEPTIDE; SYNTHETIC PEPTIDE;

ANIMAL CELL; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; ISOTOPE LABELING; MELANOMA B16; MELANOMA CELL; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PROTEIN BINDING;

ANIMALS; ANTINEOPLASTIC AGENTS; AUTORADIOGRAPHY; IODINE RADIOISOTOPES; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; NEOPLASM TRANSPLANTATION; OLIGOPEPTIDES;

EID: 0030405168     PISSN: 02511789     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Land H, Parada LF, Weinberg LA: Cellular oncogenes and multistep carcinogenesis. Science 1983;222:771-778.
2. Loeb LA: Mutator phenotype may be required for multistep carcino-genesis. Cancer Res 1991;51:3075-3079.
3. Fialkow PJ: Clonal origin of human tumors. Biochim Biophys Acta 1976;458:283-321.
4. Fidler IJ: Biological diversity in metastatic neoplasms: Origins and implications. Science 1982;217:998-1003.
5. Hepner GH: Tumor heterogeneity. Cancer Res 1984;44:2259-2265.
6. Skipper HE: The forty-year-old mutation theory of Luria and Delbrück and its pertinence to cancer chemotherapy. Adv Cancer Res 1983;40:331-363.
7. Feldman M, Eisenbach L: What makes a tumor cell metastatic? Sci. Am 1988;259:60-85.
8. Fidler IJ: Selection of successive tumor lines for metastasis. Nature 1973;242:148-149.
9. . 9 Fidler IJ, Kripke ML: Metastasis results from preexisting variant cells within a malignant tumor. Science 1977;197:893-895.
10. Hill RP: Metastasis; in Tannock IF, Hill RP: The Basic Science of Oncology, ed 2. New York, McGraw-Hill, 1992, pp 178-195.
11. Kramer RH, Gonzales R, Nicolson GL: Metastatic tumor cells adhere preferentially to the extracellular matrix underlying vascular endothelial cells. Int J Cancer 1980;26:639-645.
12. Liotta LA, Rao CN, Wiener VM: Biochemical interactions of tumor cells with basement membrane. Annu Rev Biochem 1986;55:1037-1055.
13. Terranova VP, Hujanen ES, Martin GR: Basement membrane and the invasive activity of metastatic tumor cells. J Natl Cancer Inst 1986;77:311-316.
14. Timpl R, Dziadek M: Structure development and molecular pathology of basement membranes. Int Rev Exp Pathol 1986;29:1-112.
15. Terranova V, Liotta LA, Russo RP, Martin GR: Role of laminin in the attachment and metastasis of tumor cells. Cancer Res 1982;42:2265-2269.
16. Graf J, Iwamoto Y, Sasaki M, Martin GR, Kleinman HK, Robey FA, Yamada Y: Identification of an amino acid sequence in laminin mediating cell attachment; chemotaxis and receptor binding. Cell 1987;48:989-996.
17. Iwamoto Y, Graf J, Sasaki M, Kleinman HK, Greatorex GR, Martin GR, Robey FA, Yamada Y: Synthetic pentapeptide from the B1 chain of laminin promotes B16F10 melanoma cell migration. J Cell Physiol 1988;134:287-291.
18. Daneker GW Jr, Piazza AJ, Steele GD Jr, Mercurio AM: Relationship between extracellular matrix interactions and degree of differentiation in human colon carcinoma cell lines. Cancer Res 1989;49:681-686.
19. Castronovo V, Sobel ME: Laminin and fibronectin increase the steady state level of the 67 kD high affinity metastasis-associated laminin receptor mRNA in human cancer cells. Biochem Biophys Res Commun 1990;168:1110-1117.
20. Alino SF, Unda F, Perez-Yarza G: Laminin surface binding sites and metastatic potential of 3LL tumor cells, increased by indomethacin. Biochem Biophys Res Commun 1990;167:731-738.
21. Yam HF, Chew EC, Chen HB, Wu S, Cheng-Chew SB, Yang L, Wang SW, Liew CT, Wu BQ: The 67 kD laminin receptor in high and low metastasis melanoma cell lines. Oncol Rep 1997;4:115-118.
22. Graf J, Ogle RC, Robey FA, Sasaki M, Martin GR, Yamada Y, Kleinman HK: A pentapeptide from the laminin B1 chain mediates cell adhesion and binds the 67000 laminin receptor. Biochemistry 1987;26:6896-6900.
23. Iwamoto Y, Robey FA, Graf J, Sasaki M, Kleinman HK, Yamada Y, Martin GR: YIGSR, a synthetic laminin pentapeptide, inhibits experimental metastasis formation. Science 1987;238:1132-1134.
24. Yamamura K, Kibbey MC, Jun SH, Kleinmann HK: Effect of matrigel and laminin peptide YIGSR on tumor growth and metastasis. Semin Cancer Biol 1993;4:259-265.
25. Yamamura K, Kibbey MC, Han Jun S, Kleinman H: Melanoma cells selected for adhesion to laminin peptides have different malignant properties. Cancer Res 1993;53:423-428.
26. Hunter WM, Greenwood FC: Preparation of iodine-131 labeled human growth hormone of high specific activity. Nature 1962;227:495-496.
27. Koliakos GG, Tsilibary EC, Charonis AS: A melanoma cell surface laminin binding protein with apparent Mr 90000. Connect Tissue Res 1991;26:167-180.
28. Fields GB: Synthetic: peptides and tumor cell metastasis. Pept Res 1993;6:115-120.
29. Liotta LA, Kleineman J, Saidel GM: Quantitative relationships of intravascular tumor cells, tumor vessels and pulmonary metastases following tumor implantation. Cancer Res 1974;34:997-1004.
30. Hill RP, Young SD, Cillo C, Ling V: Metastatic cell phenotypes: Quantitative studies using the experimental metastasis assay. Cancer Rev 1986;5:118-151.
31. Weiss L: Metastatic inefficiency. Adv Cancer Res 1990;54:159-211.
32. Poste G, Greig R: On the genesis and regulation of cellular heterogeneity in malignant tumors. Invasion Metastasis 1982;2:137-176.
33. Zamora PO, Eshima D, Graham D, Shattuck L, Rhodes BA: Biological distribution of 99m Tc-labeled YIGSR and IKVAV laminin peptides in rodents: 99mTc-IKVAV localizes to the lung. Biochim Biophys Acta 1993;1182:197-204.